385383-48-2

Basic information

• Product Name: [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL
• Synonyms: [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL
• CAS NO: 385383-48-2
• Molecular Formula: C11H12O3
• Molecular Weight: 192.21
• Mol File: 385383-48-2.mol

Chemical Properties

• Melting Point: 58-60°C
• Appearance: /
• CAS DataBase Reference: [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL(385383-48-2)
• EPA Substance Registry System: [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL(385383-48-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 385383-48-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
[3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL is used as a building block in the synthesis of various organic compounds due to its unique structure and functional groups.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL is used as a starting material or intermediate in the development of new drugs. Its potential biological activity makes it a promising candidate for drug discovery and development.
Used in Agrochemical Industry:
[3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL is also utilized in the agrochemical industry, where it may serve as a precursor for the synthesis of compounds with pesticidal or herbicidal properties.
Safety Note:
It is important to handle [3-METHOXY-4-(2-PROPYNYLOXY)PHENYL]METHANOL with care, as it may possess hazardous properties. Proper safety measures should be taken during its use and storage to minimize potential risks.

Upstream product

• 498-00-0 4-hydroxymethyl-2-methoxyphenol 
• 106-96-7 propargyl bromide 
• 624-65-7 2-propynyl chloride 

Relevant articles and documents

Cationic cyclotriveratrylene-based glycoconjugate and its interaction with fullerene

Fullerenes exhibit interesting biological activities both in vitro and in vivo. However, the low solubility of fullerenes in aqueous media appears to be a major problem for their biological application. To exploit water-soluble macrocyclic host systems to improve the water-solubility of fullerene, a cationic water-soluble CTV derivative containing glucosamine hydrochloride (CTV-GH) is synthesized and well characterized. The supramolecular complexation between CTV-GH and C60 was investigated in organic solvent and aqueous solution, respectively, and confirmed by fluorescence, UV-vis, and Raman spectra. The CTV derivative exhibits a distinct photoluminescence, which can be used to conveniently detect its interaction with C60 through spectrofluorometric titration. CTV-GH can bind C60 in toluene-DMSO solution with the association constant Ka = 4.36 × 10 5 M-1 calculated on the hypothesis of forming a supramolecular complex with 1:1 molar ratio at 298 K. In an aqueous solution, C60 has no absorption intensity due to its insolubility. However, in the presence of CTV-GH, a new characteristic peak of C60 at 342 nm in the UV-vis absorption spectrum was observed for the C60-CTV-GH complex and its intensity greatly increases over 24 h, which proves that CTV-GH can bind C60 in aqueous solution to form a water-soluble complex. The host-guest interaction between sugar-bearing CTV and C60 in aqueous solution will boost the potential biological applications of C60.

Scaffold optimization in discontinuous epitope containing protein mimics of gp120 using smart libraries

A diversity of protein surface discontinuous epitope mimics is now rapidly and efficiently accessible. Despite the important role of protein-protein interactions involving discontinuous epitopes in a wide range of diseases, mimicry of discontinuous epitopes using peptide-based molecules remains a major challenge. Using copper(i) catalyzed azide-alkyne cycloaddition (CuAAC), we have developed a general and efficient method for the synthesis of collections of discontinuous epitope mimics. Up to three different cyclic peptides, representing discontinuous epitopes in HIV-gp120, were conjugated to a selection of scaffold molecules. Variation of the scaffold molecule, optimization of the ring size of the cyclic peptides and screening of the resulting libraries for successful protein mimics led to an HIV gp120 mimic with an IC50 value of 1.7 μM. The approach described here provides rapid and highly reproducible access to clean, smart libraries of very complex bio-molecular constructs representing protein mimics for use as synthetic vaccines and beyond.

APOPTOSIS INHIBITORS

The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.

Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice

Three carboranyltetraphenylporphyrins containing 40 or 80 boron atoms were synthesized and evaluated for their biodistribution and toxicity in EMT-6 tumor-bearing mice. Copper (II) meso-5,10,15,20-tetrakis[3-methoxy-4-(o-carboranylmethoxy)phenyl]porphyrin

CARBORANYLPORPHYRINS AND USES THEREOF

The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing 5, 10, 15,